Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FGGY carbohydrate kinase domain-containing protein is an enzyme that belongs to the carbohydrate kinase family. It catalyzes ATP-dependent phosphorylation of D-ribulose at the C-5 position, forming D-ribulose 5-phosphate. The protein may function in metabolite repair mechanisms and the metabolism of alternative carbohydrates. In mammals, multiple isoforms are expressed, notably in skeletal muscle where expression is induced by muscle denervation and during myoblast differentiation. Overexpression in muscle cells inhibits muscle differentiation and attenuates MAP kinase and Akt signaling. While implicated in processes related to muscle atrophy, FGGY has not been clearly established as a direct therapeutic target or as having strong disease associations to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FGGY carbohydrate kinase domain-containing protein (FGGY).